معرفی
Bettina Schock is a Lecturer at the School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, affiliated with the Wellcome Wolfson Institute for Experimental Medicine. She focuses on innate immunity's role in inflammation and fibrosis, particularly in lung diseases like idiopathic pulmonary fibrosis (IPF) and systemic sclerosis-associated interstitial lung disease (SSc-ILD). Her research includes drug repurposing for fibrosis treatment and iPSC-derived fibroblast models for disease study.
Her work emphasizes translational research, collaborating with academic and industrial partners. Key projects include the 2018-2020 'Stratification of patients with 'steroid-resistant' airway inflammation by A20-DREAM' grant. She actively advises PhD students and engages in interdisciplinary research to improve therapies for chronic airway diseases.
Research trends highlight A20-DREAM axis modulation, fibroblast activation mechanisms, and biomarker discovery. Notable contributions include identifying HE4 as a fibrosis biomarker and investigating dapagliflozin's antifibrotic effects. She frequently presents at international conferences, such as the 2024 ISSEC meeting, and contributes to editorial roles.